We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Currently, there is a rapid, ongoing increase in our understanding of genetic neuromuscular disorders at the molecular level: many causative genes have been found, giving hope for targeted genetic treatments, already proven effective in some diseases. In immune-mediated neuromuscular disorders, pathogenetic mechanisms are better understood, and this enables the development of more precise immunotherapies. Increased knowledge has led to a refinement of classifications and has added numerous subtypes to the already hundreds of possible neuromuscular diagnoses. Patients can only benefit from future targeted therapies if an accurate diagnosis is made. Moreover, a diagnosis needs not only to be precise; the diagnostic trajectory needs to be swift, as current and future treatments will be aimed at the prevention or the restriction of irreversible damage.
The best way to diagnose a neuromuscular disease at this point is probably to recognize the phenotypical pattern, to know its differential diagnosis, and to proceed from there.
Neuromuscular diseases include disorders of anterior horn cells, anterior and posterior roots, plexus, peripheral nerves, neuromuscular junctions, and muscles. Detailed history and physical examination most often provide reliable information to localize the neuromuscular disorder. Motor neuron diseases have in common the dysfunction of the superior or inferior motor neuron. Immune myasthenia gravis is caused by autoantibodies interfering with the normal neuromuscular transmission. Most myopathies are slowly progressing diseases involving predominantly proximal muscles. Corticosteroids are the first-line immunosuppressive treatment in most chronic immune-mediated neuromuscular diseases. Neurological disorders may cause respiratory failure by impairing pulmonary ventilation. For normal ventilation to occur, multiple central and peripheral nervous system structures need to be intact. Respiratory management of neuromuscular respiratory failure requires differentiating between slowly developing conditions in which respiratory failure occurs as an exacerbation of a chronic condition, and rapidly progressive diseases.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.